Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Managing Anorexia During Chemoradiation With Olanzapine (MACRO)

NCT06995508 is registered in ClinicalTrials.gov with Roswell Park Cancer Institute as lead sponsor.

NCT NCT06995508
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06995508 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Managing Anorexia During Chemoradiation With Olanzapine (MACRO)
Lead sponsor
Roswell Park Cancer Institute
Phase
Phase 2
Overall status
Recruiting
Start date
December 24, 2025
Completion date
November 15, 2031
Enrollment
66 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer-associated anorexia, head and neck squamous cell carcinoma, neck squamous cell carcinoma of unknown primary